Full Event Guide
The 1st Rare & Genetic Neurodegenerative Drug Development Summit is the leading industry-dedicated meeting focused on the strategic and translational decision-making targeting genetically defined populations.
50+ experts from pharma, biotech and leading academia will be convening online, this June 2022, to uncover best-in-class approaches to find additional druggable opportunities to give potential maximal benefit and troubleshoot the relevance of models, and necessary preclinical packages to inform strategies ahead of in-human clinical trial decision making.
Join the only industry conference to facilitate discussions on how the industry is looking at genetic targets and genetic populations within neuro!
Testimonials from Related Events:
"Great group of people in the neuroscience and drug discovery field getting together to share ideas and thoughts"
William Chen, Director - Systems Biology, Biogen
"The quality of the attendees and the speakers was outstanding. The speakers were exceptional, I was blown away. I'm still trying to recover."
Mark Henry, Chief Executive Officer & Chief Financial Officer, Bach Pharma Inc.
"A very good overview of the state of the art issues that are confronting the field of neurodegeneration"
Brett Skolnick, Executive Director - Clinical Development, Gossamer Bio
"NDD provided a great opportunity for discussion, feedback, and networking alongside an all-star speaker line-up"
Samantha Hutten, Senior Associate Director - Research Partnerships & Research Programs, The Michael J. Fox Foundation for Parkinson's Research